X

Aurobindo Pharma Ltd Q2FY25; 9% rise in Profits

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159)

Financial Results:

Aurobindo Pharma Ltd reported Revenues for Q2FY25 of ₹7,796.00 Crores up from ₹7,219.00 Crore year on year, a rise of 7.99%.

Total Expenses for Q2FY25 of ₹6,725.00 Crores up from ₹6,332.00 Crores year on year, a rise of 6.21%.

Consolidated Net Profit of ₹817.00 Crores up 8.64% from ₹752.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹13.95, up 7.97% from ₹12.92 in the same quarter of the previous year.

Tags: pharma
Related Post